Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples